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Investigating the Role of Transcription Factor AP-2y in Reproduction 
Abstract 
The proper formation of gametes is critical for the propagation of species and for the 
fertility of the individual. The molecular pathways involved in gamete formation remains 
elusive, therefore, identification of genes involved is an important prerequisite to further 
our understanding of reproduction. This research will improve infertility treatments and 
prevention methods in animals and human s. We created mutants that lacked AP-2y 
transcription factor after the mouse had entered meiosis and initiated folliculogenesis. 
The AP-2y mutants were still fertile and phenotypically similar to normal mice that 
expressed AP-2y transcription factor. We also produced mutants that lacked AP-2y 
transcription factor during embryonic development at embryonic day 6.5. These mutants 
resulted in disrupted formation of primordial germ cells, during development. There were 
no germ cells present in AP-2y mutants. This data shows that AP-2y transcription factor 
is needed during embryonic germ cell development and may be involved in the 
migration, differentiation, and production of primordial germ cells. 
1 
Introduction 
The AP-2 transcription factors 
Transcription factors (TF) function to regulate genes by either up regulating or depressing 
expression of targeted genes. One family of transcription factors is the five-member AP-
2 transcription factor family. The AP-2 TF family consists of 52 kDa proteins AP-2a, 
AP-2~, AP-2y, AP-28 and AP-2£ (Eckert et al., 2005). 
AP-2 TF family orthologs can be found in many species including, Xenopus, fish, 
chickens, rats, mice and humans (Auman et al., 2002; Bauer et al., 1994; Bauer et al., 
1998; Knight et al., 2005; Luo et al., 2002; Monge et al., 2001). TF proteins contain 
different domains for protein dimerization, DNA binding, and transcriptional activation. 
In mammals, all AP-2 proteins except AP-28 are encoded for by seven exons and share 
characteristic domain structure (Eckert et al., 2005; Williams and Tjian, 1991). All 
members of the AP-2 TF family share a conserved helix-span-helix DNA binding 
dimerization motif at the carboxyl terminus. This region consists of two amphipathic a-
helices separated by a ~80 amino acid span that plays a role in DNA binding and protein: 
protein dimerization. The AP-2 transcription factors are able to form protein hetero- and 
homodimers using this region (Williams and Tjian, 1991). Similar helix-span-helix 
(HSH) motifs can be found in other DNA binding proteins myoD, E12, TFE2 and achaete 
scute daughterless (Duan et al., 1995; Gaubatz et al., 1995; Newman et al., 2001). The 
AP-2 HSH region is sufficient for protein dimerization but a downstream basic region of 
the protein is necessary to act with this region to complete DNA binding (Williams and 
Tjian, 1991). The highly conserved C-terminus HSH and centrally located basic region 
enable AP-2 proteins to recognize and bind G/C rich sequences in DNA to bind, 
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specifically the pallindromic consensus sequence 5'-GCCN 3GGC-3' which can be found 
in various enhancer sequences (Hilger-Eversheim et al., 2000). Transactivation of genes 
is achieved by a less conserved praline and glutamine rich domain at the amino terminus 
in AP-2 proteins (Eckert et al., 2005). This region yields the variability seen in the AP-2 
family members when binding target genes and activating processes such as cell growth 
and differentiation. The similarity in the AP-2 family members suggests that these 
proteins could be playing redundant roles as well as individual roles. The AP-2 genes 
have been implicated in regulating genes necessary for cell fate determination pathways 
such as proliferation , differentiation and apoptosis (Hilger-Eversheim et al., 2000; 
lmagawa et al., 1987; Luscher et al. 1989). 
Since AP-2y was identified in Pl 9 carcinoma cells, multiple other types of cancer cells 
have shown AP-2y expression suggesting that the misexpression of this transcription 
factor may lead to abnormal cell states by aberrantly inducing proliferation or 
differentiation (Friedrichs et al., 2005; Hoi-Hansen et al., 2004; Hong et al., 2005; Jager 
et al., 2005). Elevated levels of both AP-2a and AP-2y have been reported in the 25-30% 
of breast cancers that exhibit elevated levels of the critical regulatory proto-oncogene c-
erbB-2 (Bosher et al., 1996; Li et al., 2002). In breast carcinomas, research shows that 
AP-2a, ~ and y are capable of binding the c-erbB-2 promoter as hetero or homodimers 
and up regulate expression of c-erbB-2 (Bosher et al., 1996). Abundant amounts of the 
AP-2y transcript have also been identified in testicular germ cell tumors (Hoei-Hansen et 
al., 2004). AP-2y expression is regulated by retinoic acid in testicular carcinomas as 
well, further indicating the importance of retinoic acid in regulating expression of AP-2y 
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(Hoei-Hansen et al., 2004; Kopan and Fuchs, 1989). The presence of AP-2y in tumors 
suggests that it may play a vital role in regulating proliferation of cell populations. 
Study of AP-2y in the embryos by a traditional gene knockout has detected a lethal 
phenotype. AP-2y mutants fail on embryonic day 7.5 (E7.5) from failure of the embryos 
to implant caused by defects in the extraembryonic tissues (Auman et al., 2002) (Winger 
et al., 2006). 
Primordial germ cells in the developing gonad 
Germ cells are first specified from a pool of proximal epiblast cells that will migrate, 
proliferate, populate the gonad, undergo meiosis and result in specialized gametes for 
their ultimate role in reproduction-successful fertilization. The primordial germ cells 
migrate by amoeboid movement from the proximal epiblast towards the primitive streak 
and then up into the embryonic gonad termed genital ridge. It will eventually form the 
gonads and any primordial cells that do not reside in genital ridge will be degenerated. As 
primordial germ cells are colonizing the genital ridges, they are undergoing mitosis and 
their numbers increase significantly (the growth number is dependent upon genetic 
regulation of proliferation and survival rates of PGCs). After populating the genital 
ridge, in the female, they differentiate into primordial follicles which are diploid oocytes 
surrounded by a single layer of squamous follicular cells. The oocyte is considered 
primary because it has yet to carry out meiosis division I. Before birth, the diploid 
primary oocytes enter a final round of DNA synthesis and are then arrested in prophase I 
of the first meiotic division until shortly before ovulation; thus, a primary oocyte may 
remain in prophase I for most of a female's reproductive life. The reproductive program 
required in the development of the gonad requires the coordinated expression of several 
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genes necessary to control these events. Several gene mutation studies have resulted in 
models of reproductive failure and many are genes involved in regulation of germ cells 
(McLaren, 2003; Rajkovic et al., 2004). We have discovered that a gene mutation in the 
transcription factor AP-2y prevents germ cell development. 
Folliculogenesis and spermatogenesis 
Folliculogenesis is the process where ovarian follicles develop from primary into 
secondary and eventually into antral follicles that become eligible for ovulation. 
Ovulation is the process in the estrus cycle by which a mature ovarian follicle ruptures 
and discharges the oocyte. Folliculogenesis is initiated at birth and first ovulation is at 
puberty. (Senger, 2003). The genes involved in maintenance of folliculogenesis remain 
elusive. There are many genetic diseases, such as familial ovarian failure and 
galactosaemia that cause early ovarian failure in woman. Understanding the molecular 
pathways involved in folliculogenesis maintenance could help us discover preventative 
methods for young woman and animals that are faced with premature ovarian failure. 
Spermatogenesis takes place within semineferous tubules. It is the process where 
spermatozoa are formed, consisting of proliferation (mitosis), meiosis and differentiation. 
It starts at puberty and usually continues uninterrupted till death (Senger, 2003). 
AP-2y expression in the gonads 
AP-2y transcripts have been detected using RT-PCR at embryonic day (E) 12.5, 










Figure 1, AP-2y mRNA in fetal 
gonads. RT-PCR detection of mRNA in 
male and female gonads. 
In addition, AP-2y is present in the ovary as 
detected by RT-PCR . The location of AP-2y 
rnRNA within the adult ovary was detected by 
in situ hybridization , and is definitely in the 
oocyte but also is expressed in the granulosa 
cells surrounding the oocyte. 
Potential role of AP-2y in the gonad 
To determine the role of AP-2y in the ovary, it 
was necessary to use a conditional mutation because a traditional gene KO resulted in an 
early lethal phenotype. Therefore, to study the mutation in the adult ovary Cre-loxP 
technology was used. The Cre-loxP technology was derived from the Pl bacteriophage. 
The Cre protein is a recombinase that recognizes a 34-bp sequence called a loxP site. Cre 
recombinase is expressed in a tissue specific manner to detect a floxed portion of the AP-
2y gene and delete that portion of the DNA. The term "floxed" refers to a gene that 
contains a functionally important coding region of a gene bracketed by 2 loxP sites. The 
loxP sites forces the site of specific deletion of this critical portion of the allele when Cre 
recombinase is expressed (Fig 2). A mouse that contains loxP sites bracketing exon 6 of 
the AP-2y gene has been created and in the absence of Cre are viable and fertile proving 
that the floxed or conditional AP-2y allele is functional. The effectiveness of Cre deletion 
has also been demonstrated and is verified by PCR using specific primers that detect 
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different bands for the floxed allele, for the Cre deleted allele, and for the wild type 
allele. 
loxP site -
l7 ....---......_ -  
AP-2y floxed allele 
.~ - .,__,____.._.  
AP-2y deleted allele 
( after Cre Exposure) 
Figure 2, Loss of function mutation of AP-2y achieved by Cre recombinase 
The More-Cre mouse expresses Cre in the epiblast at E6.5 and therefore mutates AP-2y 
in the entire embryo while leaving the trophoblast lineage intact, to bypass the lethal 
mutation and produce mice that are adult AP-2y mutants. Majorities of these mutant mice 
are born healthy and survive through adulthood. They are fertile when they first reach 
maturity. However, the common adult female phenotype is for the reproductive 
productivity to drop off beginning around 5 months of age with complete infertility often 
observed around 7 months. The infertility in these animals is due to the failure of the 
ovaries to produce follicles. This is illustrated by histological sections of ovaries that 
show the number of follicles in the mutant ovaries that are greatly decreased and often 
entirely absent (Fig 3). The premature ovarian failure is perhaps a result of a reduced 
number of germ cells. 
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Figure 3, Comparison of follicle production in ovaries from mice at 
7 months of age. The ovary on the left is a wild-type which contains 
several large follicles. The ovary on the right is an AP-2y mutant which 
is completely lacking follicles 
This result does confirm a reproductive phenotype; however the More-Cre deletion is not 
complete in the gonad . It appears to be the case in the adult female because the mice that 
contained the More-Cre, AP-2y null allele, and an AP-2y floxed allele were mated to wild 
type males and were unable to produce any offspring that contained a recombined floxed 
allele. This same result was detected in males . 
Therefore, to further investigate the hypothesis that AP-2y plays a role in gamete 
formation, we wanted to create a conditional mutation in adults to study the role of AP-2y 
during folliculogenesis and spermatogenesis. Moreover, we want to use a conditional 
mutation with complete recombinase activity. If our mice become infertile, with no sperm 
or eggs present, it illustrates that AP-2y is involved in differentiation of germ cells, or in 
gamete formation after folliculogenesis and spermatogenesis has been initiated. 
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Materials and Methods 
Producing adult AP-2y knockout mice 
ERTM-CRE mice were purchased from Jackson labs and these mice will be expressing 
AP-2y until induced to produce the AP-2y mutation. This commercially available mouse 
contains a fusion protein between the Cre and the mutated form of the ligand binding 
domain of the estrogen receptor (Cre-ER tm*). The mutated receptor is no longer 
capable of binding its natural ligand (17b-estradiol) but will bind to, and can be induced 
by, exogenously injected tamoxifen (TM). This gene is ubiquitously expressed, driven by 
the ~-actin promoter, but the recombinase protein is sequestered to the cytoplasm by 
Hsp90 and unable to enter the cell nucleus and cleave the DNA. Binding of TM by the 
ERTM receptor removes the Hsp90 and allows the active Cre into the nucleus (Hayashi 
et. al., 2002). ERTM-Cre mice were mated to female mice that were homozygous for AP-
2y floxed allele. ERTM-Cre and AP-2y null genotypes of mice in the breeding colony 
were determined using polymerase chain reaction (PCR) performed on tissues. For timed 
pregnancies, specific matings were set up in the afternoon, and the mice were checked for 
vaginal plugs in the morning. 
Producing AP-2y knockout fetuses 
Sox2Cre mice were purchased from Jackson labs and Cre recombinase activity is 
restricted to the epiblast The Cre recombinase gene sequence is regulated by a 12.5 kb 
upstream regulatory sequence from the Sox2 gene, wherever there is up regulation of the 
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Sox2 gene, Cre recombinase will also be expressed, producing a targeted gene deletion in 
these cells. Sox2Cre is expressed in epiblast cells, which means that gene recombination 
of a target gene, will take place only in the embryonic po1tion of conceptsus allowing the 
placental tissues to develop with normal gene expression. Sox2-Cre recombinase is 
activated at E6.5 (Hayashi et al., 2002). 
Sox2-Cre mice were mated to female mice that were homozygous for AP-2y floxed 
allele. Sox2-Cre, AP-2y null and AP-2y flox genotypes of mice in the breeding colony 
were determined using polymerase chain reaction (PCR) performed on tissues. For timed 
pregnancies, specific matings were set up in the afternoon, and the mice were checked for 
vaginal plugs in the morning . 
Genotyping Mice 
The presence of ERTM-Cre or Sox2-Cre transgene, AP-2y null and AP-2y flox alleles 
were determined using PCR. For the Sox2-Cre experiment, fetuses were dissected from 
the sacrificed mother at E16.5 and El8.5 , and tail samples from the fetuses were 
collected and placed in lysis buffer containing proteinase K for tissue homogenation. 
For the ERTM-Cre experiment, tail samples were collected from 3 week mice and placed 
in lysis buffer containing proteinase K for tissue homogenization . In addition , after the 
mice were injected with tamoxifen, PCR determined AP-2y flox deletion. PCR reactions 
to detect these genes were carried out for 35 cycles (94°C, 40 sec; 67°C, 40 sec; 72°C, 40 
sec) in a buffer containing: .2mM of each dNTP, lµM of each primer, 1 µM Taq DNA 
polymerase (Fermentas, Hanover, MD) 4mM MgCb and approximately lµg genomic 
DNA. Following thermocycling, product was loaded on a 2% agarose gel containing 




Cre 1 F- 5' - GCT GGT TAG CAC CGC AGG TGT AGA G - 3' 
Cre 1 R - 5' - CGC CAT CCT CCA GCA GGC GCA CC - 3' 
AP-2y KO primers 
Neo 3 KO - 5' -AAC GCA CGG GTG TTG GGT CGT TTG TTC G - 3' 
Xgamma 3 - 5' - CCT TCT GCT CTC TGG CCT CCT TGC AGC C - 3' 
Gamma WT 5 - 5' -TCA TGG CTT TGG CAG CCA GGC CAT C - 3' 
AP-2y flox deleted primers 
GamXbSq F-5'-GAG TTA GAG AGC AAG TTA CAG GCT G-3' 
GamSq3 R-5'-CTT GGA ACT CAC TTT GTA GCT GAG G-3' 
Injections of ERTM-Cre adult mice 
Tamoxifen was dissolved in corn oil at a concentration of lOmg/ml. TM was injected 
intraperitoneally into adults at 3mg per 40 g of body weight every other day for 6 days. 
Then 3-4 months later, mice were reinjected, at 9mg per 40 g of body weight for 5 
consecutive days, or a single injection at 9mg per 40 g of body weight for 5 consecutive 
days with TM dissolved in l 5mg/ml of corn oil was used. 
BrdU immunohistochemistry 
Bromodeoxyuridine (5-bromo-2deoxyuridine, BrdU) is a synthetic nucleoside that is an 
analog of thymidine. Brdu is commonly used in detection of proliferating cells in living 
culture. BrdU was dissolved in phosphate-buffered saline at 3µg/ml and two injections of 
BrdU (50µg/g of body weight) and was administered intraperitoneally into male mice 1 
hour apart . Mice were euthanizedl hour after the second injection (Wang and Hardy, 
2004). 
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lmmunochemistry was performed on testes that were subjected to BrdU. Testes were 
embedded in paraffin and sectioned in Sµm thick sections. Slides were deparaffinized, 
and incubated for 10 minutes in 3% H202 in PBS to block endogenous peroxidase 
activity. Slides were thoroughly rinsed in Tris-buffered saline with tween 20(TBST). 
Slides were then boiled for 10 minutes in working solution BDtm Retrievagen A, and 
allowed to cool to room temperature. Biotinylated anti-BrdU antibody 1: 10 in TBST and 
slides were incubated for one 1 hour. Next, Streptavidin-HRP was applied to each slide 
and incubated for 30 minutes. Then DAB substrate solution (prepared by adding 1 drop 
of DAB chromogen to 1 ml of DAB buffer) was applied and incubated for 5 minutes. 
Slides were counterstained in hematoxylin for 15 seconds and rinsed thoroughly with 
water. Slides were dehydrated and visualized at 20X or 40X using an Olympus BX40 
microscope. 
Histology and oocytes counts for adult AP-2y mutant ovaries 
Ovaries were fixed, paraffin-embedded and serially sectioned at Sµm. Serial sections 
were stained with hemotoxylin and eosin, and every sixth slide was counted. The average 
number of oocytes per section was calculated and significant differences in oocytes 
numbers between mutants and wild types was determined by student T-test. 
Immunohistochemistry of embryonic ovaries 
Ovaries were embedded in agarose and paraffin using standard histology procedure and 
sectioned Sµm thick and mounted on glass slides. Slides were then deparaffinized and 
thoroughly washed in TBST. Slides were boiled in 10 mM sodium citrate for 10 minutes 
and washed in TBST. Addition of the Nobox primary monoclonal IgG goat antibody was 
added for 1 hour and was followed by incubation with fluorophore-conjugated polyclonal 
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IgG anti-goat secondary antibody for 1 hour (Rajikovic et al, 2004). Then Vector VIP 
purple substrate solution (Vector labs) was applied to each slide and incubated for 3 
minutes. Slides were then rinsed, dehydrated and visualized at 40X using an Olympus 
BX40 microscope. 
Detection of AP-2y mutant gametes 
Four ERTM-Cre knockout females were mated to wild-type males, and four ERTM-Cre 
knockout males were mated to wild-type females. Both were bred at 60, 90, and 130 days 
after the last tamoxifen injection. 
Dissections 
ERTM-Cre mutant ovaries were dissected at 30, 60, and 190 days after the last injection. 
Males were dissected 200 days after last injection of tamoxifen and 1 hr after last 
injection of BrdU 
One ovary or testis from each animal was washed in phosphate-buffered saline and then 
fixed in 10% neutral buffered formalin for 12-48 hours and processed using standard 
paraffin for histology. 
The other teste or ovary was washed in phosphate-buffered saline and then used for RNA 
extraction . Tail samples from each mouse were collected in lysis buffer containing 
proteinase K for genotype verification . 
Sox2-Cre mutant embryos were dissected 18.5 days post coitus (dpc). Ovaries were 
washed in phosphate-buffered saline and fixed in 10% neutral buffered formalin for 12-
48 hours and then processed using standard paraffin for histology. Tail samples from 
each embryo were collected and put in lysis buffer containing proteinase K for 
genotyping. 
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Detection of AP-2y mRNA transcripts 
Total RNA was collected and extracted from AP-2y mutant mice and WT mice 
using the RNea sy isolation kit according to manufacturer 's specifications (Qiagen, Santa 
Clarita, Ca). RNA samp les were quanitated using Eppendorf BioPhotometer.(Eppendorf 
AG, Hamburg) cDNA was then prepared from .8µg of total RNA. RT-PCR reaction s to 
detect AP-2y were carried out for 35 cycles (94°C, 40 sec; 67°C, 40 sec; 72°C, 40 sec) in 
a buffer containing 25mM MgC12. For AP-2y transcript detection , RT-PCR primer 
sequences were designed to anneal in exons 6 and 7 of the AP-2y gene, producing a 206 
bp band from the WT allele . This primer set was also used to confirm complete deletion. 
These primers would not amplify AP-2y null or AP-2y floxed deleted alleles but would 
amplify WT and AP-2y floxed allele s. These primers were used to ensure that the AP-2y 
mutant animals we created did not show the presence of AP-2y transcript. Prim er 
sequences: 
AP-2y floxed primers 
AP-2y F- 5' - AAG CGG TGG CTG ACT ATT TAA- 3' 
AP-2y R - 5' - CAG GCT GAA ATG AGA CAA ACA G - 3' 
RT Real Time PCR to quantitate expression in adult AP-2y mutant ovaries 
Ovary samples were taken from adult mice 60 days after last injection with tamoxifen. 
RNA was extracted using the RNeasy isolation kit according to manufacturer 's 




Biophotomenter. Reverse transcription was performed as noted above. Real Time 
reactions were prepared to compare AP-2y mRNA levels using Taqman probes (Applied 
Biosystems, Foster City, Ca). Reactions were set up according to manufacturer's 
specifications and run on a Biorad iCycler (2 min 50°C, 10 min 95°C, Cycle 40 times at 
15 sec 95°C and 1 min 60°C). A standard curve was run with ten fold cDNA dilutions 
which were used for quantification and analysis of experimental results. 
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RESULTS 
234 5 6 7 8 9 -· -
Genotypes were verified by 
PCR , for ERTM-Cre and AP-
2y null alleles (Fig 4). The AP -2y 
Null ··-······ •• If ---
mice that contained correct 
allele combination were 
CRE 
KO KO 
injected with tamoxifen and 
deletion of AP-2y was 
verified by PCR (Fig. 5). 
Figure 4,AP-2y deletion does not affect folliculogenesis 
To determine if the ERTM-Cre deletion was complete, RT-PCR was run, which detected 
AP-2y expression in ERTM-CRE mutant mice 
(Fig 6). The RT-PCR shows a decrease in 
expression, but it is not quantifiable, therefore 
Real time RT-PCR (qRT-PCR) was run and 
confirmed that AP-2y mRNA levels were 60% 
of WT after injection with tamoxifen 
KO WT KO KO 
Figure 5. Verification of AP-2y floxed 
deleted alleles after injection with tamoxifen 
(lower band) . WT lack Cre allele, therefore 
AP-2y is not deleted, and AP-2y is shown with 
all exons present (higher band). Product sizes: 
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Figure 6, RT-PCR detection of 
AP-2ytranscripts in AP-2y mutant 
ovaries and WT ovaries . Product 




Figure 7, qRT-PCR detection of AP-2y. AP-2y expression was reduced to 60% in the ERTM-Cre 
mutant mice (KO) compared to wild-types (WT) . 
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Female s were able to produce oocytes after ERTM-Cre TM induced mutation . The 
mutant ovarie s looked morphologically similar to wild-types (Fig 8). 
KO WT 
Figure 8, ovary sections stained with hemotoxyln and Eosin show that AP-2y 
mutants produce oocytes. 
Oocyte number s were not different in mutant ovarie s at 30, 60, and 190 days after TM 
injecti on (Table 1). 
Table 1, Oocyte numbers in AP-2y mutant ovaries 
Days post KO WT Significance 
injection 
30 2.0 ± 1.4 10.5 ± 0.7 ND 
60 8.3 ±2.7 17.6 ± 3.9 P=0.12 
190 ~.7 ±0.9 6.0 ± 2.1 P=0.43 
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Four knockout females were mated to wildtype males and had a total of 24 pups. Out of 
24 pups, 14 did not have the CRE allele, and out of the 14 pups without CRE, 4 pups had 
the AP-2y-deleted allele, and 5 pups had the AP-2y null allele. Pups with deleted AP-2y 
allele indicates that deleted oocytes can produce viable offspring. In addition, out of the 
14 that did not have Cre allele, 5 pups had the floxed AP-2y allele which shows 
incomplete recombinase activity in the ovary (Table 2). 
Table 2, Genotypes of pups from ERTM-Cre TM induced female mice bred to WT male 
mice. 
wt/Gamflox wt/AP-2y wt/ Total# of 
null Gamflox offspring 
deleted 
Day 60 2 1 1 4 
Day 90 0 1 0 1 
Day 130 3 3 3 9 
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AP-2y does not affect spermatogenesis 
The testes sectio ns looked morphologic ally similar between mutant and wild type testes. 
The mutant mice had semi niferou s tubule s and spermatozoa production . (Fig 9). 
KO WT 
Figure 9, mutant testes morphologicall y similar to WT testes. Sections of teste stained 
with hemotoxyln and Eosin 
Immunohistochemisty detection of sper matogon ia using BrdU (Fig 10) showed 




Figure 10, Detection of proliferating cells (brown ) using BRDU. Mutant males have ge rmline stem ce lls. 
Four knockout male s were mated to wild type females. There were a total of IO 1 pups . 
Out of 101 pups, 53 did not have Cre allele, and out of the 53 without Cre, 25 pups had 
AP-2y deleted alle le, zero pups had the AP-2y floxed allele, and 28 pups had the AP-2y 
null allele (Table 3). The se results show that sperm are still viable even after AP-2y allele 
has been deleted . It also shows that there is comp lete recombinase activity in male 
gonads becau se none of the pups had AP-2y floxed allele. 
21 
Table 3, Genotypes of pups from ERTM-Cr e TM induced male mice bred to WT female mice. 
wt/Gamflox wt/AP-2y null Wt Total# of 
Gamflox deleted offspring 
Day 0 6 7 13 
60 
Day 90 0 9 7 16 
Day 0 13 11 24 
130 
This data shows that AP-2y deletion in adults can still produce viable oocytes and 
spermatazoa. However, this does not explain the More-Cre pre ovarian failure. The loss 
of oocytes in our More-Cre is probably due to AP-2y deletion during germ line 
development in the embryo (More-Cre turns on at E6.5). Therefore, to study the role of 
AP-2y during primord ial germ cell deve lopment, we mutated AP-2y in the epiblast using 
Sox2-Cre. 
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AP-2y plays a role during primordial germline development 
PCR used to detect Sox2-Cre and AP-2y null genotypes. 





Figure 11, Detection of AP-2y gene 
expression. Full deletion of all AP-2y mRNA 
transcripts was verified by performing RT-PCR 
on RNA samp les of AP-2y WT and AP-2y null 
embryos . Product size 200 bp 
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Histology on 18.5 mutant ovarie s illustrate s that Sox2 -Cre mutant s have a germ cell 
phenotype (Fig 12). Fetal ovarie s collected from El8.5 mutant embryo s fail to produce 
any cell s that contain the germ cell marker protein , Nobox . 
WT KO 
.. 
Figure 12, Detection of germ cells in the ovary at E18.5. 
Nobox prote in detec ted by immun ohistoc hemistry is show n by 
purpl e co lor. AP-2y mut ant on the right shows a lac k of Nobox 
pos itive ce lls in the ova ry co mpare d to the litterm ate co nt ro l 
(WT ) on the le ft. 
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Discussion 
AP-2y transcripts were still expressed in female gonads after injection with TM, which 
complicates the ERTM-Cre model for studying gene mutations in the ovary. However, 
this result did not effect the conclusion that AP-2y does not play a role during 
folliculogenesis in adults, because AP-2y deleted oocytes were still able to produce viable 
offspring. In addition, the number of oocytes was not significantly different between AP-
2y deleted ovaries and wild-type ovaries. 
AP-2y deletion was complete in male gonads. This was shown when we bred ERTM-Cre 
mutant males to wild-type females , and none of their pups carried an undeleted AP-2y 
floxed allele. In addition, AP-2y does not affect spermatogenesis, because AP-2y deleted 
spermatozoa were able to produce viable offspring. AP-2y deletion does not affect the 
rate of sperm production . Spermatogonia are germ line stem cells that will proliferate and 
differentiate into spermatozoa . Decreased number of spermatogonia will decrease number 
of spermatozoa produced . BrdU stained spermatogonia within the male gonad, and the 
number of spermatogonia were no different between mutants and wild-types. Overall, 
AP-2y does not play a role in maintaining folliculogenesis and spermatogenesis in adults. 
Interestingly through our data, supports a role for AP-2y in regulating germ cell 
development during embryonic gonad formation in the mouse. lmmunohistochemistry of 
embryonic fetuses lacked Nobox, which is an oocyte-specific homeobox gene expressed 
in germ cell cysts and in primordial and growing oocytes. (Rajkovic et al., 2004). Nobox 
is essential for postnatal follicle development. Lack of Nobox expression was presumably 
due to loss of PGCs which was due to deletion of AP-2y in the fetal ovary. 
25 
More-Cre AP-2y null mice had a decrease in the number of follicles, and only oocytes 
that had expression of AP-2y ever developed into ovulated follicles needed for 
reproduction . The More-Cre phenomenon is due to the deletion occurring during 
development of gonads, however, an incomplete deletion causes a decrease in infertility 
rather than complete infertility at puberty. Our data confirm that transcription factor AP-
2y is needed for fertility during embryonic development. 
AP-2y transcription factor regulates genes needed for fertility. Identifying how AP-2y is 
involved in the molecular pathways of reproductive success will be useful. It will allow 
people to diagnose unsolved cases of infertility, discover treatments, and preventative 
methods in animals as well as humans . 
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